clinical trial · NCT05642325
Vamikibart in Participants With Uveitic Macular Edema
Hoffmann-La Roche·phase3·completed·n = 256
Uveitic Macular EdemaVamikibartSham
brief summary
This study will assess the efficacy and safety of vamikibart in participants with uveitic macular edema.
started
Mar 23, 2023
primary completion
May 7, 2025
completion
Dec 24, 2025
last updated
Apr 17, 2026
official title
A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Investigate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Vamikibart Administered Intravitreally in Patients With Uveitic Macular Edema
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol